Obesity Screening in Hospitalized Pediatric Patients: Rates of Diagnosis, Intervention, and Risk Factors for

Shir Libman1, Michal Vinker-Shuster2, Zvi Perry3

  • 1Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.

Insights

Pediatric obesity diagnoses are frequently missed during hospital stays, particularly in young children. Healthcare providers need training to identify and address obesity non-stigmatizingly in hospitalized youth.

Area of Science:

  • Pediatric Healthcare
  • Obesity Medicine
  • Clinical Informatics

Background:

  • Recent guidelines highlight the critical need for obesity diagnosis and management across all healthcare settings.
  • However, obesity is underrepresented as a chronic diagnosis in hospital records, with limited data on interventions.
  • This study addresses the gap in understanding obesity diagnosis and management during pediatric acute care.

Purpose of the Study:

  • To evaluate the frequency and patterns of obesity-related diagnoses and interventions in hospitalized children.
  • To compare the characteristics of children diagnosed with obesity versus those overlooked.
  • To identify factors associated with missed obesity diagnoses in pediatric acute care.

Main Methods:

  • A retrospective cohort study analyzed hospitalization records for patients aged 2-18 years over 30 months.
  • Weight-for-age percentiles were calculated using CDC charts; ≥95th percentile indicated suspected obesity.
  • Obesity-diagnosed and obesity-overlooked patient groups were compared.

Main Results:

  • 8.6% of hospitalized patients (245/2827) met criteria for suspected obesity.
  • Only 15.5% (38/245) were formally diagnosed with obesity, and 17.9% received weight-related discharge recommendations.
  • Obesity was significantly more likely to be overlooked in preschoolers (aOR 11.78) and patients without abdominal complaints (aOR 7.7).

Conclusions:

  • Obesity diagnoses are infrequent during pediatric acute hospitalizations, with younger children being particularly vulnerable to being overlooked.
  • Pediatric healthcare professionals require enhanced training for recognizing and addressing obesity.
  • Implementing non-stigmatizing interventions for pediatric obesity during hospitalization is crucial.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include: